Sharon L. Edelstein

Milken Institute — United States

Medicine · Health Sciences

60h-index12.5kcitations232works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes Management and Research(36), Diabetes, Cardiovascular Risks, and Lipoproteins(35), Diabetes Treatment and Management(35), Metabolism, Diabetes, and Cancer(30), Diet and metabolism studies(22)

Publications200 total

Longitudinal metabolic trajectories in Diabetes Prevention Program participants reveal subgroups with varying micro and macrovascular complication risks
2025Open Access
Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks
Diabetes Care·2025· 2 citedOpen Access
Analysis of Long-term Follow-up of a Randomized Clinical Trial With Departures From Assigned Treatments: Estimation of Metformin Effects on Diabetes and Its Complications in the Diabetes Prevention Program Outcomes Study
Diabetes Care·2025Open Access
Analysis of long-term follow-up of a randomized clinical trial with departures from assigned treatments: Estimation of metformin effects on diabetes and its complications in the Diabetes Prevention Program Outcomes Study
2025Open Access
Analysis of long-term follow-up of a randomized clinical trial with departures from assigned treatments: Estimation of metformin effects on diabetes and its complications in the Diabetes Prevention Program Outcomes Study
2025Open Access
Longitudinal metabolic trajectories in Diabetes Prevention Program participants reveal subgroups with varying micro and macrovascular complication risks
2025Open Access
The 2018 World Cancer Research Fund/American Institute for Cancer Research Score and Cancer Risk: results from the diabetes prevention program outcomes study
American Journal of Clinical Nutrition·2025· 1 citedOpen Access
Supplemental Table S4 from Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program
2025Open Access
Supplemental Table S2 from Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program
2025Open Access
DPPOS Investigators from Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program
2025Open Access
Supplemental Table S3 from Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program
2025Open Access
Supplemental Table S1 from Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program
2025Open Access
Data from Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program
2025Open Access
Nonglycemic and glycemic risk factors for painful neuropathic symptoms and for distal symmetrical polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
2025Open Access
Nonglycemic and glycemic risk factors for painful neuropathic symptoms and for distal symmetrical polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
2025Open Access
Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study
Diabetes Care·2025· 1 citedOpen Access
713-P: Relationship between Magnitude of Weight Loss and Cardiovascular Outcomes in the Diabetes Prevention Program (DPP) and Its Outcomes Study (DPPOS)
Diabetes·2025
Long-term effects and effect heterogeneity of lifestyle and metformin interventions on type 2 diabetes incidence over 21 years in the US Diabetes Prevention Program randomised clinical trial
The Lancet Diabetes & Endocrinology·2025· 15 citedOpen Access
Randomized Study of Metformin and Intensive Lifestyle Intervention on Cancer Incidence over 21 Years of Follow-up in the Diabetes Prevention Program
Cancer Prevention Research·2025· 7 citedOpen Access
Long-term impact of Diabetes Prevention Program interventions on walking endurance
Frontiers in Public Health·2024· 2 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Elizabeth Barrett‐Connor(20), Steven E. Kahn(13), William C. Knowler(12), Kieren J. Mather(10), Richard F. Hamman(7), John M. Lachin(7), Kristen J. Nadeau(7), Kristina M. Utzschneider(7), George A. Bray(6), Santica M. Marcovina(6), Jill P. Crandall(6), Silva Arslanian(6), Sonia Caprio(6), Philip Zeitler(6), Karla A. Temple(6), Elena Barengolts(6), Babak Mokhlesi(6), Eve Van Cauter(6), Susan Sam(6), Brenda K. Montgomery(6)